Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 Jan 28;12(2):132–137. doi: 10.1016/j.clml.2011.12.005

Table 4.

Overall Survival (OS) from Time of First High-Risk FISH Analysis for the Entire Cohort by Mutational Analysis

N Median (95% CI) (Years) 3 Years Log Rank P HR 95% CI
OS: All Patients 66 5.4 (3.1,5.6+) 67 (53, 84)
OS, By Mutational Status
    Low IGVH Mutation (< 2) 50 4.5 (2.0, 6.2+) 55 (39, 78) .02 1.00 -
    High IGVH Mutation (2+) 16 NR 100 (100, 100) .15 (0.02, 1.2)
OS: Patients With del(11q)
    Low IGVH Mutation (< 2) 28 11.3 (11.3, 19.9+) 70 (49, 98) .31 1.00 -
    High IGVH Mutation (2+) 11 NR 100 (100, 100) .37 (0.04, 3.1)
OS: Patients With del(17p)
    Low IGVH Mutation (< 2) 22 1.9 (1.2, 5.6+) 34 (15, 78) .02 1.00 -
    High IGVH Mutation (2+) 5 NR 100 (100, 100) a

Values for median survival are in years. Other values are survival probability (95% CI).

Abbreviations: Hazard ratio could not be estimated because no deaths occurred in the patients with del(17p) mutated IGVH sequence.